Medication info

MULTIBIG 4 POTASSIUM SOLUTION 5L

Prescription medicationInjection
Ingredient · strength
Potassium Chloride›5.964gCalcium Chloride Hydrate›4.41gMagnesium Chloride Hexahydrate›2.033gGlucose Hydrate›22gSodium Chloride›6.453gSodium Bicarbonate›3.104gSodium›Strength being verifiedPotassium›Strength being verifiedCalcium›Strength being verifiedMagnesium›Strength being verifiedChlorine›Strength being verifiedHydrocarbonate›Strength being verifiedGlucose›Strength being verified
Manufacturer / importer
Fresenius Medical Care Korea Ltd.
Appearance
A colorless and transparent liquid preparation contained in a transparent plastic bag.
Packaging
200 units/box [5,000 mL per unit]
Approval status
Active

MFDS item code 201103798 · Notified 2011.06.14 · Insurance code 664300590

Summary

Main use
Continuous renal replacement therapy for acute renal failure and acute poisoning with water-soluble toxins
Who receives it
Adults
Adult administration
Must be administered under the direction of an experienced physician. 1) In acute renal failure, a dose of 2,000 mL/h is appropriate for waste removal in a 70 kg adult patient, depending on the patient's metabolic level. The dose should be adjusted according to the patient's body size. 2) The dose and duration of hemodialysis, hemofiltration, and hemodiafiltration required to treat symptoms of acute poisoning vary depending on the toxin and its concentration, as well as the severity of the clinical symptoms, and should be determined according to the patient's condition. 3) A maximum daily dose of 75 L is recommended.

Ingredients

Importer
Fresenius Medical Care Korea Ltd.

Efficacy & effects

Continuous renal replacement therapy for acute renal failure and acute poisoning with water-soluble toxins

View approved original text

This medication is used for patients who require continuous renal replacement therapy due to acute renal failure. Additionally, it can be utilized as a fluid substitute or dialysis solution during hemodialysis and blood filtration, aiding in the removal of water-soluble toxins. It is particularly suited for patients with normal blood potassium levels and effectively improves toxin elimination while supporting renal function during treatment. Therefore, it is very useful for the treatment of acute renal failure and its related symptoms.

How it is given

Adult administration

Must be administered under the direction of an experienced physician. 1) In acute renal failure, a dose of 2,000 mL/h is appropriate for waste removal in a 70 kg adult patient, depending on the patient's metabolic level. The dose should be adjusted according to the patient's body size. 2) The dose and duration of hemodialysis, hemofiltration, and hemodiafiltration required to treat symptoms of acute poisoning vary depending on the toxin and its concentration, as well as the severity of the clinical symptoms, and should be determined according to the patient's condition. 3) A maximum daily dose of 75 L is recommended.

Precautions

This drug should not be used in certain patients. It should not be administered to patients allergic to any component of this medication or those with elevated blood potassium levels, as well as patients with metabolic alkalosis. Additionally, patients in a state of excessive metabolism or who do not have sufficient blood flow, as well as those at high risk of bleeding, should not use this drug. When using this drug, various side effects may occur. For example, gastrointestinal issues such as nausea or vomiting, fluctuations in blood pressure, muscle cramps, etc., may arise. Additionally, symptoms such as shortness of breath or leg swelling may manifest due to excess or deficiency of bodily fluids, so caution is necessary. During treatment, it is important to periodically check potassium levels in the blood, and appropriate measures should be taken if the potassium level is too low or too high. Sodium levels should also be regularly tested to prevent side effects due to rapid changes. Calcium, magnesium, phosphate, glucose, acid-base balance, as well as body weight and fluid status should be continuously monitored to identify any abnormal signs early. This drug may not adequately replenish important nutrients during hemodialysis or blood filtration, so appropriate nutritional supplementation may be necessary if needed. When used with other medications, interactions may occur; thus, it is essential to adhere to dosage guidelines and closely monitor the patient's condition. In particular, caution should be exercised for signs of toxicity when used with medications such as digitalis. Pregnant or breastfeeding women should avoid this drug unless specifically required, as its safety has not been thoroughly established. There is insufficient data on the safety and efficacy of this drug in children, so its use is not recommended. In the case of overdose, imbalances in bodily fluids and electrolytes may occur, so prompt adjustment or discontinuation of treatment should be implemented upon symptom onset. Before use, be sure to mix the two solutions and warm them to a temperature similar to body temperature before infusion, ensuring the solution is clear and free of foreign substances. During the use of this drug, white precipitate may form in the infusion tube, so it should be checked regularly, and if any precipitate is observed, it should be replaced immediately. Store in a sealed container to protect from air and moisture. It is advisable to maintain the storage temperature between 4°C and 30°C, which will help retain the drug's efficacy and safety for a longer duration.

Side effects

  • Nausea
  • vomiting
  • hypotension
  • hypertension
  • muscle cramps
  • hypervolemia
  • dehydration
  • electrolyte imbalance
  • hypophosphatemia
  • hyperglycemia
Show 10 more
  • metabolic alkalosis
  • shortness of breath
  • ankle and leg edema
  • dizziness
  • thirst
  • abnormal blood osmolarity
  • arrhythmia
  • congestive heart failure
  • pulmonary congestion
  • muscle rigidity and spasms

Not everyone experiences these, and they can vary from person to person.

Storage

This drug must be stored in a sealed container to protect it from air and moisture. It is recommended to maintain the storage temperature between 4°C and 30°C. This helps in preserving the drug's efficacy and safety for an extended period.

Appearance and packaging

Appearance

A colorless and transparent liquid preparation contained in a transparent plastic bag.

Package unit

200 units/box [5,000 mL per unit]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.